Pfeiffer P, Glimelius B, Winther S, Qvortrup C, et al. Randomised trial of cetuximab every 2 weeks with FOLFIRI or cetuximab with alternating FOLFIRI/FOLFOX in patients with RAS and BRAF wild type metastatic colorectal cancer: Nordic 8 results. Ann Oncol 2019;30 Suppl 4:iv131.
PMID: 32085034